Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.
$QIPT
Misc Health and Biotechnology Services
Health Care
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 6)
|
Quipt Home Medical Corp. (Name of Issuer) |
Common Shares (Title of Class of Securities) |
74880P104 (CUSIP Number) |
Robert MacArthur
c/o Forager Fund, L.P.,, 2025 3rd Avenue North, Suite 350
Birmingham, AL, 3520
205-383-4763
c/o Forager Fund, L.P.,, 2025 3rd Avenue North, Suite 350
Birmingham, AL, 3520
205-383-4763
Heidi Steele
McDermott Will & Schulte LLP,, 444 West Lake St, Suite 4000
Chicago, IL, 60606
312-984-3624
McDermott Will & Schulte LLP,, 444 West Lake St, Suite 4000
Chicago, IL, 60606
312-984-3624
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
03/16/2026
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP Number(s): | 74880P104 |
| 1 |
Name of reporting person
Forager Fund, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP Number(s): | 74880P104 |
| 1 |
Name of reporting person
Forager Capital Management, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IA |
SCHEDULE 13D
|
| CUSIP Number(s): | 74880P104 |
| 1 |
Name of reporting person
Kissel Edward Urban | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN, HC |
SCHEDULE 13D
|
| CUSIP Number(s): | 74880P104 |
| 1 |
Name of reporting person
MacArthur Robert Symmes | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN, HC |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Shares | |
| (b) | Name of Issuer:
Quipt Home Medical Corp. | |
| (c) | Address of Issuer's Principal Executive Offices:
1019 TOWN DRIVE,, WILDER,
KENTUCKY
, 41076. | |
Item 1 Comment:
This Amendment No. 6 ("Amendment No. 6") amends the statement on Schedule 13D filed with the SEC on December 16, 2025 (as amended from time to time, the "Schedule 13D") with respect to the shares of the Issuer. This Amendment No. 6 to Schedule 13D amends Items 4 and 5 as set forth below. Capitalized terms used herein and not otherwise defined have the meanings set forth in the Schedule 13D/A. | ||
| Item 2. | Identity and Background | |
| Item 3. | Source and Amount of Funds or Other Consideration | |
| Item 4. | Purpose of Transaction | |
Item 4 is hereby amended and supplemented as follows:
On March 16, 2026, pursuant to the Arrangement Agreement and Plan of Arrangement, the previously announced Arrangement among the Issuer, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware company (individually, "REM Aggregator," and collectively with B.C. Purchaser, "Purchaser" or "Purchasers") was completed, upon which all issued and outstanding common shares of the Issuer were acquired by Purchasers for cash consideration of $3.65 per share, without interest. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | Item 5(a) is hereby amended and restated in its entirety as follows:
As of the close of business on the date hereof, the Reporting Persons no longer may be deemed to beneficially own any common shares. | |
| (b) | Item 5(b) is hereby amended and restated in its entirety as follows:
As of the close of business on the date hereof, the Reporting Persons no longer may be deemed to beneficially own any common shares. | |
| (c) | Item 5(c) is hereby amended and restated in its entirety as follows:
Except as described herein with respect to the closing of the Arrangement, the Reporting Persons have not effected any transactions in the common shares of the Issuer during the past sixty days. | |
| (e) | Item 5(e) is hereby amended and restated in its entirety as follows:
March 16, 2026 | |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
| Item 7. | Material to be Filed as Exhibits. | |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|